SIRT1 and pancreatic adenocarcinoma: Moreover, low SIRT1 expression was found to inhibit PAAD cell viability and rescue the pro-effect of the miR-30b-5p inhibitor (See Supplementary Fig. 7c–e, Online Resource 2).